Clinical Trials Browser

Withdrawn × Tretinoin × Clear all

NCT01048086 2016-06-21

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

Phase 2 Withdrawn

CNSEndocrineNET

Neuroblastoma, Neuroendocrine Tumors

NCT01067274 2015-12-30

ALFA-0703

Phase 3 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01349556 2014-04-23

Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream

Phase NA Withdrawn

Neoplasms, Drug-Related Side Effects and Adverse Reactions